|
Assessing clonal fitness and mechanisms of clonal evolution in FPD-MN |
Memorial Sloan-Kettering Cancer Center |
The RUNX1 Research Program |
|
Modeling familial platelet disorder associated RUNX1 mutations in mice |
University of Massachusetts Medical School |
The RUNX1 Research Program |
|
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause |
|
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause |
|
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause |
|
Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion |
Research Institute at Nationwide Children's Hospital |
Cure4Cam Childhood Cancer Foundation |
|
Multivalent Nanomedicine to Treat High-Risk Pediatric Solid Tumors |
Children's Hospital of Philadelphia |
Flashes of Hope |
|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope, Tap Cancer Out |
